Filing Details

Accession Number:
0001622627-25-000011
Form Type:
13G Filing
Publication Date:
2025-02-12 19:00:00
Filed By:
Rosalind Advisors, Inc.
Company:
Spruce Biosciences Inc.
Filing Date:
2025-02-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Rosalind Advisors, Inc. 0 0 0.0%
SALAMON STEVEN A J 0 0 0.0%
Aharon Gil 0 0 0.0%
Rosalind Master Fund L.P. 0 0 0.0%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:02/13/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:02/13/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:02/13/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:02/13/2025